Ozempic, Wegovy among drugs selected for Medicare's price negotiations
The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare Part-D for price negotiations, the next round of negotiations under the Inflation Reduction Act passed by President Joe Biden in 2022.
Wegovy and Ozempic top list of 15 drugs up for next price negotiations
Blockbuster weight-loss and diabetes drugs Wegovy and Ozempic top the list of 15 drugs selected for the second round of federal price negotiations, which are scheduled to begin this year, with resulting bargained prices going into effect in 2027.
Type 2 diabetes is a condition where the body doesn’t make enough of the hormone insulin or use it effectively. Here, MDs ...
In a small randomized trial, people who took capsules containing donated gut microbiomes experienced fewer gastrointestinal ...
A common vegetable could help treat or prevent type 2 diabetes due to its effect on blood sugar and the gut, according to new ...
Semaglutide (known by its brand name Ozempic) has gained widespread attention for its weight-loss benefits, but is officially ...
If you came here wondering what prediabetes means, we’ll answer it simply: Prediabetes, often considered the step before ...
New data suggest Restylane Lyft or Contour in combination with Sculptra corrects contour deficiencies in patients experiencing facial volume loss following medication-driven weight loss ...
Could an ordinary carrot improve the treatment of type 2 diabetes? A new study from SDU suggests so. The researchers found ...
Imagine reversing a life-altering condition without the use of drugs. One British GP is doing exactly that, and his ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback